ProtAffin's Series A - II Round

ProtAffin raised a round of funding on January 14, 2008. Investors include Entrepreneurs Fund.

ProtAffin is a pre-clinical biotechnology company developing protein-based products countering inflammation. Its biologics targets the heparin-like glycan structures that drive inflammatory processes…

Articles about ProtAffin's Series A - II Round: